Published medical evidence has shown that compounds from medicinal fungi significantly stimulate the immune system. There is research ongoing worldwide regarding, for example, β-glucan’s efficacy in cancer therapy and infectious disease.

GlycaNova has presently one clinical and two preclinical pharmaceutical products.

There is an additional pipeline of products, in which immune stimulating properties have been demonstrated. These products are not fully characterized.